Bone Density
GE LunarTM bone densitometry is a painless, non-invasive and safe test used to diagnose osteoporosis. Bone density is measured at the hip and spine with high accuracy and precision, yet with very low exposure to radiation.
GE Lunar bone densitometers continue to set new landmarks in clinical value with high-performance applications, advanced clinical utility and the unique enCORETM software platform.
This direct-digital detector technology delivers rapid scans, near radiographic imaging and dose efficiency three- to five-times better than existing fan beam systems. Plus, its comprehensive capabilities cover a complete range of applications.
enCORETM optimizes productivity with automation breakthroughs that save time and ensure consistent results. And paperless digital reporting makes densitometry results accessible quickly and easily.
Why measure bone density?
Diagnosis of Osteoporosis
When diagnosing osteoporosis, physicians rely on a personal examination, as well as a test that provides physicians with what is known as a T-score. Lunar Bone Densitometry, a high tech, noninvasive and painless test, assesses the spine and femur bones and calculates the T-score. Each bone’s density is measured and categorized with precision. The T-score, classified by the World Health Organization (WHO) as normal, osteopenic or osteoporotic, will then help the doctor determine a prevention or treatment plan.
Fracture Risk Assessment
The bone mineral density (BMD) test is a way to predict the risk of future bone fractures. It is the strongest tool to predict fracture risk, which increases exponentially as BMD decreases. Femur (leg bone) BMD is recognized as the strongest predictor of femur fracture risk, which has the highest morbidity, mortality and cost of all osteoporotic fractures.
Monitoring Changes in BMD
Patients may return for bone density tests every one to three years, depending on the expected rate of loss and their clinical situation. BMD may increase over time as a response to therapy, or it may decrease with disease progression or poor response to therapy. Precision (reproducibility) of the BMD measurements is the key factor in detecting changes in the patient’s BMD over time.